Results
eNauka >
Rezultati >
Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis
| Naziv: | Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis | Autori: | Otasevic, Vladimir; Antić, Darko A.   ; Maiti, Kausik; Cho, Heidi; Lunney, Nancy; Dabic, Darko; Learn, Chris |
Godina: | 2025 | Publikacija: | Blood (67th Annual Meeting of the American Society of Hematology (ASH), Dec 6-9, 2025, Orlando, USA) | ISSN: | 0006-4971 Blood Pretraži identifikator |
Izdavač: | [New York] : Elsevier | Tip rezultata: | Konferencijski rad | Kolacija: | vol. 146 br. Suppl 1 str. 6315-6316 | DOI: | 10.1182/blood-2025-6315 | WoS-ID: | 001669463500015 | URI: | https://enauka.gov.rs/handle/123456789/1028453 | URL: | https://ashpublications.org/blood/article/146/Supplement%201/6315/550815/Risk-of-bleeding-in-chronic-lymphocytic-leukemia | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.